Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Boosting your savings for a house down payment is essential. Discover key tips that can help you increase your funds and prepare for homeownership.
18,205 articlesIn 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Broadcom surges after expanding its custom-chip partnership with Apple through 2031, boosting peers like AMD and Inte...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
A Goldman Sachs survey finds most small businesses are using AI with optimism about revenue gains, but only a minorit...
A wealth-building story stretches from early America to today’s markets. This guide shows how history informs investi...
A sweeping proposal to overhaul the H-1B visa program introduces a six-figure filing fee and merit-based criteria, ai...
A leaked exchange allegedly shows Trump telling Netanyahu, ‘you’re crazy,’ prompting a sharp market reaction as trade...
A looming court decision and budget pressures place the consumer financial protection bureau at a crossroads, with co...
New projections shift the timeline for potential Social Security cuts earlier, prompting retirees and savers to rethi...
A mixed quarter and a tougher backdrop pushed KE Holdings shares lower, underscoring how market forces and sector hea...
At Fortune Brainstorm Tech in Aspen, top executives say AI will augment human work—taking on repetitive tasks while p...
Meta is pressing ahead with a sweeping AI infrastructure plan even after laying 8,000 employees. CEO Mark Zuckerberg ...